COMMUNIQUÉS West-GlobeNewswire

-
CORRECTING and REPLACING -- Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update
27/02/2019 - 18:05 -
Loop Industries Announces $5.1 Million Registered Direct Offering
27/02/2019 - 18:00 -
Novozymes A/S’ annual shareholders’ meeting 2019
27/02/2019 - 17:46 -
RAMSAY GENERALE DE SANTE : half year results at the end of December 2018
27/02/2019 - 17:36 -
RAMSAY GENERALE DE SANTE : résultats semestriels à fin décembre 2018
27/02/2019 - 17:36 -
MEDIA ADVISORY: Logan Boulet’s family to announce inaugural Green Shirt Day
27/02/2019 - 17:35 -
Nova Leap Health Corp. Announces Execution of Letter of Intent (LOI) to Acquire Home Care Services Business in Eastern Canada
27/02/2019 - 16:00 -
BioRestorative Therapies Announces the Creation of a Disc Advisory Committee
27/02/2019 - 15:45 -
SRS Health to Showcase Top-Rated Orthopedic Solutions Suite at 2019 Annual OrthoForum Meeting
27/02/2019 - 15:37 -
Trident Brands, Brain Armor and NorthShore University HealthSystem Provide Update on Brain Health Research Collaboration
27/02/2019 - 15:30 -
Phoenix Life Sciences International Announces Michael Gobel as Finance Advisor
27/02/2019 - 15:00 -
Evolus Appoints Crystal Muilenburg as Vice President Corporate Communications & Public Relations
27/02/2019 - 15:00 -
Agritek Holdings, Inc. Announces CEO Webcast Interview with Uptick Newswire Discussing Expansion Into Cannabis Edibles and Beverages in Multiple Regulated Jurisdictions
27/02/2019 - 15:00 -
Obalon Announces First Commercial Use of Navigation and Touch Products for Obalon Balloon Administration
27/02/2019 - 15:00 -
Sarepta Therapeutics Announces Positive and Robust Expression and Biomarker Data from the First Three-Patient Cohort Dosed in the MYO-101 Gene Therapy Trial to Treat Limb-Girdle Muscular Dystrophy Type 2E, or Beta-Sarcoglycanopathy
27/02/2019 - 15:00 -
Kamada Files Annual Report for the Year Ended December 31, 2018
27/02/2019 - 15:00 -
Canopy Rivers Completes Previously Announced Bought Deal and Concurrent Private Placement for Total Gross Proceeds of Approximately $93.5 Million
27/02/2019 - 14:48 -
CV Sciences, Inc. to Present and Exhibit at Natural Products Expo West 2019 in Anaheim, California, March 5-9, 2019
27/02/2019 - 14:45 -
Precision Therapeutics Inc. Announces Pricing of Public Offering of Up to $1.26 Million of Units
27/02/2019 - 14:36
Pages